| ID | Name | CAS | Data |
MW (g/mol) |
| 24-071-6 |
Imidazole, 2,3-dihydro-1-methyl-2-acetylimino-3-acetyl-4acetyloxy-
|
|
3 | 239.23 |
| 24-647-7 |
allo-Cholanic acid, 3«beta»,7«alpha»,12«alpha»-trihydroxy, Me-DMES
|
|
3 | 681.22 |
| 24-886-2 |
4-CHLORO-3-(3-METHYL-5-OXO-2-PYRAZOLIN-1-YL)BENZENESULFONIC ACID
|
|
3 | 288.71 |
| 24-913-1 |
2-Pyrazoline, 4,4-dimethyl-5-(1-methylethyl), 1-benzoyl
|
|
3 | 244.33 |
| 25-006-7 |
Silanamine, 1,1,1-trimethyl-N-[4-[(trimethylsilyl)oxy]phenyl]-
|
52726-86-0 |
3 | 253.49 |
| 25-019-3 |
2,3,5,6,7,8-Hexahydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
88491-50-3 |
3 | 190.24 |
| 25-282-1 |
[(7R)-7-Hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl hexanoate
|
|
3 | 253.34 |
| 25-289-4 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»-ol (stigmastanol), DMESI
|
|
3 | 502.93 |
| 25-753-8 |
O-Ethyl-O-(1,1-difluoro-2-bromoethyl)-N-metyl-phosphorothioamidate
|
|
3 | 298.09 |
| 25-842-9 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, isobutyl ester
|
|
3 | 339.38 |
| 25-902-2 |
1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, decahydro-
|
18161-94-9 |
3 | 194.27 |
| 25-971-6 |
2-Amino-4,6-dihydroxypyrimidine, N,O,O'-tris(pentafluoropropionyl)-
|
|
3 | 565.15 |
| 26-069-7 |
2,6-Pyridinedicarboxylic acid, 2-methylbutyl 2-methylhex-3-yl ester
|
|
3 | 335.44 |
| 26-538-6 |
Thiazolo[3,2-a]pyridinium, 8-hydroxy-3,5-dimethyl-, hydroxide, inner salt
|
|
3 | 179.24 |
| 26-677-2 |
(Z)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, bis-PFB-oxime, # 1
|
|
3 | 630.47 |
| 26-737-5 |
5«alpha»-Pregnane-3«alpha»,20«alpha»,21-triol, TMS
|
|
3 | 553.05 |
| 26-784-3 |
cis-N-(1-Bicyclo[2.2.1]heptyl-N'-(1-adamantyl)diazene
|
|
3 | 258.41 |
| 26-810-3 |
3,3,7,7-Tetramethyl-1,5-diazabicyclo[3.3.0]octane
|
2940-98-9 |
3 | 168.28 |
| 27-368-4 |
allo-Cholanic acid, 7«alpha»,12«alpha»-dihydroxy, Me-DMES
|
|
3 | 579.01 |
| 27-489-0 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-4-one, 1,2,3,7,9,10,11,13,14,14a-decahydro-, [7S-(7«alpha»,14«alpha»,14a«alpha»)]-
|
35611-60-0 |
3 | 246.35 |
| 27-524-0 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
20422-70-2 |
3 | 211.34 |
| 27-752-7 |
5-Pregnen-3-«beta»-ol-11,20-dione, MO-TMS
|
|
3 | 460.72 |
| 27-825-6 |
allo-Cholanic acid, 3«alpha»,7«alpha»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 27-834-6 |
Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1S-[1«alpha»,7(2R*,3R*),7a«alpha»]]-
|
480-83-1 |
3 | 299.36 |
| 27-941-7 |
Furan-3-carboxylic acid, 4-methyl-2-(2-methoxycarbonylethyl)-5-(4-hydroxypentyl), methyl ester
|
|
3 | 312.36 |
| 28-380-9 |
5-«alpha»-Androstan-3-«alpha»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 406.67 |
| 28-396-2 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl-7,7-pentamethylene
|
|
3 | 236.32 |
| 28-430-3 |
4-Quinolinol,4-ethenyl-1-ethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«alpha»,8a«beta»)
|
38463-57-9 |
3 | 223.35 |
| 28-574-4 |
2-(N-n-hexyl-n-n-octylamino)-3-(n-nonyl) pyrazine
|
116402-86-9 |
3 | 417.71 |
| 28-753-5 |
5-«alpha»-Pregnan-3-«alpha»-16-«alpha»-diol-20-one, TMS
|
|
3 | 478.86 |
| 28-768-9 |
2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-benzo[1,3]dioxol-5-yl-propan-1-ol, TMS
|
|
3 | 460.60 |
| 28-866-0 |
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-1,3,7-trimethyl-
|
|
3 | 210.19 |
| 29-109-9 |
N-(5,6-Dichloro-1,3-benzothiazol-2-yl)acetamide
|
|
3 | 261.13 |
| 29-171-0 |
Acetamide, N-phenyl-N-[1-(1-phenyl-2-propyl)-4-piperidinyl]-
|
90736-19-9 |
3 | 336.47 |
| 29-281-8 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro-6-methyl-
|
|
3 | 164.21 |
| 29-375-4 |
4-Quinolinol, 4-ethynyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
14788-65-9 |
3 | 207.31 |
| 29-453-7 |
[(3R)-7-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (E)-3-methylpent-2-enoate
|
|
3 | 253.34 |
| 29-716-5 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«beta»,8a«alpha»)
|
38463-56-8 |
3 | 221.34 |
| 29-886-7 |
5-«beta»-Cholestan-3-«beta»,7-«alpha»,12-«alpha»-triol, TMS
|
|
3 | 637.21 |
| 29-986-6 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
20431-95-2 |
3 | 209.33 |
| 30-026-9 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
20422-72-4 |
3 | 211.34 |
| 30-247-4 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 9-methyl
|
|
3 | 160.17 |
| 30-334-7 |
1-(P-chlorophenyl)-3-(o-hydroxyphenyl)-2-propen-1-oxime
|
116557-94-9 |
3 | 273.71 |
| 30-400-3 |
5,5'-Diphenyl-[2,2'-azo-1,3,4-thiadiazole]
|
101279-08-7 |
3 | 350.42 |
| 30-619-1 |
2-Amino-4,6-dihydroxypyrimidine, N,O,O'-tris(trifluoroacetyl)-
|
|
3 | 415.12 |
| 30-948-6 |
allo-Cholanic acid, 3«alpha»,7«alpha»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 31-179-9 |
«alpha»-D-Xylopyranose, 1,2,3,4-tetrakis-O-(trimethylsilyl)-
|
14251-20-8 |
3 | 438.85 |
| 31-195-1 |
Thiazolo[3,2-a]pyridinium,3,8-dihydroxy-,hydroxide,inner salt
|
35143-55-6 |
3 | 167.19 |
| 31-530-8 |
2,6-Pyridinedicarboxylic acid, isopropyl 2-methylhex-3-yl ester
|
|
3 | 307.38 |
| 31-696-5 |
Cholanic acid, 3«alpha»,7«alpha»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 31-791-9 |
5-Acetamino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile
|
|
3 | 479.19 |
| 31-952-0 |
2-([(Dimethylamino)methylene]amino)-3-(3-chloro-4-butyloxy-phenyl)propanoic acid, butyl ester
|
|
3 | 382.93 |
| 31-960-1 |
2-(2,4-Dichlorophenyl)-1-(1,2,4-triazol-1-yl)hexan-2-ol, trimethylsilyl ether
|
|
3 | 386.39 |
| 32-105-9 |
1,1,3,3-Tetrabutyl-1,3-bis[(trichloroacetyl)oxy]distannoxane
|
52112-07-9 |
3 | 806.63 |
| 32-132-9 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, octyl ester
|
|
3 | 429.48 |
| 32-182-4 |
4-Cyclopropanecarbonyl-3,5-bis(trimethylsilanyloxy)cyclohexa-2,5-diene-carboxylic acid, ethyl ester
|
|
3 | 396.63 |
| 32-318-3 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, isobutyl ester
|
|
3 | 373.37 |
| 32-527-1 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol, bis(trimethylsilyl) ether
|
10426-36-5 |
3 | 436.82 |
| 32-570-3 |
Phosphorothioic acid, S-[2-[(1-cyano-1-methylethyl)amino]-2-oxoethyl] O,O-diethyl ester
|
3734-95-0 |
3 | 294.31 |
| 32-611-7 |
Prosta-5,11-dien-1-oic acid, 9-oxo-11,15-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester, (5Z,11«alpha»,13E,15S)-
|
39003-20-8 |
3 | 569.01 |
| 32-772-9 |
7H-imidazo[4,5-d]-v-triazin-4-ol, 7-butyl-, (keto form)
|
|
3 | 193.21 |
| 32-797-2 |
N-(5,6-Dichloro-1,3-benzothiazol-2-yl)-2,2,3,3,3-pentafluoropropanamide
|
|
3 | 365.11 |
| 32-817-9 |
5,5-Diethyl-2-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 184.24 |
| 33-526-1 |
1-[[(1S)-2,3,4,6,7,8,9,9a-Octahydro-1H-quinolizin-1-yl]methyl]pyrrolidine-2,5-dione
|
|
3 | 250.34 |
| 33-821-3 |
Androst-5-ene-3«beta»,17«beta»-diol-16-one, TMS
|
|
3 | 520.97 |
| 33-888-0 |
Phosphoric acid, 7-chlorobicyclo[3.2.0]hepta-2,6-dien-6-yl dimethyl ester
|
23560-59-0 |
3 | 250.62 |
| 33-942-9 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 2-methylpentyl ester
|
|
3 | 349.46 |
| 34-074-2 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 3-methyl
|
|
3 | 164.21 |
| 34-097-7 |
Isonipecotinoylisonipecotic acid, N'-(2,5-di(trifluoromethyl)benzoyl)-, propyl ester
|
|
3 | 522.48 |
| 34-142-6 |
4,4'-Bis(2-amino-1-naphthylazo)-2,2'-stilbene disulfonic acid
|
5437-12-7 |
3 | 678.74 |
| 34-583-7 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, hexyl ester
|
|
3 | 367.43 |
| 34-606-1 |
N-(2,2,3,3,4,4,4-Heptafluorobutanoyl)-N-(4-methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
|
|
3 | 572.27 |
| 34-609-8 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 7-methyl
|
|
3 | 160.18 |
| 34-872-6 |
Methyl 5-«beta»-cholan-3-«beta»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 563.96 |
| 35-400-8 |
5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 474.88 |
| 35-412-5 |
1,3,2-Diazaphosphol-4-ene, 2,4-dichloro-1,3-dicyclohexyl-
|
|
3 | 321.23 |
| 35-572-8 |
1,3,5,2,4,6-Triazatriphosphorine, 2,2,4,4,6,6-hexabromo-2,2,4,4,6,6-hexahydro-
|
13701-85-4 |
3 | 614.37 |
| 35-819-4 |
5-methylaceto-5'-(3-buten-1-ynil)-2,2'-bithienyl
|
|
3 | 272.39 |
| 35-938-2 |
5«alpha»-Pregnane-3«beta», 20«beta», 21-triol, MO TMS
|
|
3 | 553.05 |
| 36-159-6 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, decyl ester
|
|
3 | 457.53 |
| 36-250-4 |
epi-5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 474.88 |
| 36-417-9 |
O-Ethyl-O-(1,1-difluoro-2-bromoethyl)-N-(1-methylpropyl)-phosphorothioamidate
|
|
3 | 340.17 |
| 36-761-7 |
5-Pregnen-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS
|
|
3 | 810.41 |
| 36-817-5 |
1H-Indole-3-ethanol, 2-(5-ethenyl-1-azabicyclo[2.2.2]oct-2-yl)-, [1S-(1«alpha»,2«alpha»,4«alpha»,5«beta»)]-
|
482-28-0 |
3 | 296.41 |
| 36-920-0 |
2,5,5-Trimethyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 170.21 |
| 36-921-9 |
2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-
|
309-29-5 |
3 | 378.51 |
| 37-009-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
3 | 593.04 |
| 37-178-4 |
1,3-Dimethyl-5-(3-hydroxycyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
3 | 252.27 |
| 37-265-7 |
allo-Cholanic acid, 3«alpha»,7«alpha»,12«alpha»-trihydroxy, Me-DMES
|
|
3 | 681.22 |
| 37-313-3 |
1,5,6-Triazabicyclo[3.1.0]hexane, 4-methyl-2,2,6-tris(trifluoromethyl)-4-phenyl-
|
|
3 | 379.23 |
| 37-388-1 |
4-Cyclopropyl-6-methyl-N-acetyl-N-phenylpyrimidin-2-amine
|
|
3 | 267.33 |
| 37-448-4 |
1-«beta»,3-«alpha»,12-«alpha»-Trihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
3 | 639.14 |
| 37-522-1 |
trans-(±)-5-hydroxy-«alpha»,«alpha»,4-trimethylcyclohex-3-ene-1-methanol
|
32226-54-3 |
3 | 170.25 |
| 37-683-3 |
5-«beta»-Pregnan-3-«alpha»-ol-20-one, MO-TMS
|
|
3 | 419.72 |
| 37-942-5 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, pentadecyl ester
|
|
3 | 579.67 |
| 38-104-4 |
2-(N-Ethyl-N-m-tolyl)aminoethanol, (3-cyanopropyl)dimethylsilyl ether
|
|
3 | 304.51 |
| 38-108-0 |
D-Tryptophan, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 418.49 |
| 38-174-7 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl-7,7-tetramethylene
|
|
3 | 222.29 |
| 38-214-2 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, undecyl ester
|
|
3 | 471.56 |
| 38-365-5 |
5-(3-Dimethylaminopropyl)-10,11-dihydro-5h-dibenz-[b,f]-azepine, hydrochloride
|
|
3 | 316.88 |
|
« Previous Results
Next Results »
|